Evie Koslosky
Stock Analyst at Goldman Sachs
(3.53)
# 2,249
Out of 5,028 analysts
53
Total ratings
70%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterated: Buy | $250 | $221.21 | +13.01% | 6 | Oct 5, 2026 | |
| GRAL GRAIL | Reiterated: Hold | $75 → $120 | $154.08 | -22.12% | 4 | Oct 5, 2026 | |
| ADPT Adaptive Biotechnologies | Initiated Coverage: Buy | $35 | $29.84 | +17.29% | 1 | Sep 29, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | $75 | $83.55 | -10.23% | 1 | Sep 22, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $175 → $185 | $171.29 | +8.00% | 5 | Sep 20, 2026 | |
| BRKR Bruker | Reiterated: Sell | $40 → $50 | $63.86 | -21.70% | 5 | Sep 20, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $27 → $35 | $30.39 | +15.17% | 3 | Sep 20, 2026 | |
| GH Guardant Health | Reiterated: Buy | $210 → $225 | $187.22 | +20.18% | 8 | Sep 20, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Hold | $1,340 → $1,510 | $1,541.63 | -2.05% | 4 | Sep 20, 2026 | |
| NTRA Natera | Reiterated: Hold | $270 → $375 | $425.64 | -11.90% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 → $140 | $157.36 | -11.03% | 3 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $18.55 | +29.38% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 → $515 | $440.12 | +17.01% | 4 | Sep 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $685 | $676.76 | +1.22% | 1 | Dec 9, 2025 |
Danaher
Oct 5, 2026
Reiterated: Buy
Price Target: $250
Current: $221.21
Upside: +13.01%
GRAIL
Oct 5, 2026
Reiterated: Hold
Price Target: $75 → $120
Current: $154.08
Upside: -22.12%
Adaptive Biotechnologies
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $29.84
Upside: +17.29%
Tempus AI
Sep 22, 2026
Initiated Coverage: Hold
Price Target: $75
Current: $83.55
Upside: -10.23%
Agilent Technologies
Sep 20, 2026
Reiterated: Buy
Price Target: $175 → $185
Current: $171.29
Upside: +8.00%
Bruker
Sep 20, 2026
Reiterated: Sell
Price Target: $40 → $50
Current: $63.86
Upside: -21.70%
Caris Life Sciences
Sep 20, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $30.39
Upside: +15.17%
Guardant Health
Sep 20, 2026
Reiterated: Buy
Price Target: $210 → $225
Current: $187.22
Upside: +20.18%
Mettler-Toledo International
Sep 20, 2026
Reiterated: Hold
Price Target: $1,340 → $1,510
Current: $1,541.63
Upside: -2.05%
Natera
Sep 20, 2026
Reiterated: Hold
Price Target: $270 → $375
Current: $425.64
Upside: -11.90%
Sep 20, 2026
Reiterated: Hold
Price Target: $100 → $140
Current: $157.36
Upside: -11.03%
Sep 20, 2026
Reiterated: Buy
Price Target: $24
Current: $18.55
Upside: +29.38%
Sep 20, 2026
Rated: Buy
Price Target: $425 → $515
Current: $440.12
Upside: +17.01%
Dec 9, 2025
Initiated Coverage: Buy
Price Target: $685
Current: $676.76
Upside: +1.22%